CytoDyn
@cytodyn.com
CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
CytoDyn's Company Logos
CytoDyn's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#44D62C
Lima
68, 214, 44
112, 67, 51
68, 0, 79, 16
#99A8D0
Polo Blue
153, 168, 208
224, 37, 71
26, 19, 0, 18
#63459D
Royal Purple
99, 69, 157
260, 39, 44
37, 56, 0, 38
About CytoDyn
CytoDyn Inc. With an emphasis on developing Leronlimab, a monoclonal antibody CCR5 receptor antagonist, CytoDyn aims to revolutionize treatment across a wide range of indications. Leronlimab targets the crucial immunologic receptor CCR5, found on various cells including white blood cells and cancer cells.
By preventing HIV from using the CCR5 receptor as an entry gateway for healthy cells, Leronlimab demonstrates its unique efficacy. Additionally, preclinical research shows that it also blocks calcium channel signaling of the CCR5 receptor on cancer cells, an important factor in cancer metastasis. CytoDyn's dedication to scientific advancements and breakthroughs has made them leaders in the field.
With a highly experienced team and a robust pipeline, they continue to drive innovation and offer hope to patients worldwide. For inquiries regarding their groundbreaking developments, including Leronlimab, their science, or for any questions, reach out to CytoDyn. Stay informed about their latest updates by signing up for their email alerts.
CytoDyn Inc., shaping the future of targeted medicine
